Managingip.com Website Review

interesting details from apple injunctions in qualcomm’s china cases. the fuzhou intermediate people’s court in china has granted two preliminary injunctions against four chinese subsidiaries of apple for a delaware jury finds edwards lifesciences infringed a transcatheter heart valve technology patent, which was ruled invalid by the ptab a top eu adviser has told the cjeu it should stop german courts from applying the country’s ancillary copyright rules in a case involving google because the eu commission was not informed of when the legislation was introduced simon portman of marks & clerk an*lyses issues that crop up for academic researchers commercialising medical technology innovation in the uk, one of the biggest of which is simply underestimating the value of their ideas ibm’s manny schecter believes public awareness of intellectual property has increased but there has not been a corresponding increase. africa: trade mark opposition highlights the issue of reclas*ification. in-house counsel say the epo technical board of appeal’s conclusion that plants made from essentially biological processes are patentable could usher in another decade of protection uncertainty in the industry a self-service airport baggage drop system and a medical imaging apparatus were the winners at the recent designeuropa awards. managing ip interviewed representatives of both winning companies about their successful products. uk pregabalin ruling “increases patent applicant burden”, say drug companies. innovator and generics drug companies share their reaction to the judgment in warner-lambert v generics. one in-house lawyer explains that it will be particularly detrimental to small innovator companies and “does not reflect the scientific reality of drug development”. the race to patent blockchain is fragmented – ant financial’s ip head. benjamin bai of ant financial believes patenting pure algorithms, pure compilation of information and pure business methods will be the